Alaunos Therapeutics TCRT Insider Ownership

NASDAQ TCRT
$1.55 -0.04 (-2.52%)
As of: Sep 9, 2026 · 3:08 PM EDT

Insider Holdings by Owner

99.07K Shares

Insider Ownership Statistics

as of 31 Mar, 2026
Insider Ownership
0.0003%
0% pp QoQ
Shares Held by Insiders
7
filed for Mar 2026
0.00% QoQ
Shares Outstanding
2.18Mn
2,183,039 shares
Direct Holdings
7
Indirect: 0
Net Shares Traded (QoQ)
0
no net change in Mar 2026
Insiders Holding Shares
8
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 31 Mar, 2026

TCRT's three largest insider shareholders as of September 09, 2026 are Jaime Vieser (Director, 47.64K shares), Holger Weis (Ceo, 25.48K shares), Michael Allen Jerman (Director, 23.76K shares).

Form 4 Holdings

Insiders Holding TCRT

Insiders 8
Shares held 99.07K
Of outstanding 4.54%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Jaime Vieser Director 47,642 0 47,642 48.1% 27 Jul, 2026
2 Holger Weis Ceo 25,483 0 25,483 25.7% 11 Aug, 2026
3 Michael Allen Jerman Director 23,759 0 23,759 24.0% 27 Jul, 2026
4 Kevin S. Sr. Boyle Chief Executive Officer 1,330 0 1,330 1.3% 05 Sep, 2023
5 Groot Eleanor De Evp, Operations 395 0 395 0.4% 27 Dec, 2021
6 James Huang Director 314 0 314 0.3% 24 Jun, 2022
7 Mary Thistle Director 75 0 75 0.1% 24 Jun, 2022
8 Christopher Bowden Director 74 0 74 0.1% 24 Jun, 2022

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

603 Insider Transactions

Source SEC Form 4
Latest quarter Mar 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
06 Aug, 2026 Holger Weis Ceo Acquired A 4,363 $2.01 $8.77K 25,483 Direct
23 Jul, 2026 Michael Allen Jerman Director Acquired A 8,138 $1.92 $15.62K 23,759 Direct
23 Jul, 2026 Holger Weis Ceo Acquired A 4,568 $1.92 $8.77K 21,120 Direct
23 Jul, 2026 Jaime Vieser Director Acquired A 8,789 $1.92 $16.87K 47,642 Direct
30 Jun, 2026 Holger Weis Chief Executive Officer Acquired A 3,880 $2.26 $8.77K 16,552 Direct
12 Jun, 2026 Holger Weis Chief Executive Officer Acquired A 7,761 $2.26 $17.54K 12,672 Direct
22 May, 2026 Holger Weis Chief Executive Officer Acquired A 3,700 $2.37 $8.77K 4,911 Direct
29 Apr, 2026 Michael Allen Jerman Director Acquired A 6,032 $2.59 $15.62K 15,621 Direct
29 Apr, 2026 Jaime Vieser Director Acquired A 6,515 $2.59 $16.87K 38,853 Direct
12 Jan, 2026 Jaime Vieser Director Acquired A 5,839 $2.89 $16.87K 32,338 Direct
21 Nov, 2025 Michael Allen Jerman Director Acquired A 4,183 $3.16 $13.22K 4,183 Direct
21 Nov, 2025 Jaime Vieser Director Acquired A 5,340 $3.16 $16.87K 26,499 Direct
18 Aug, 2025 Holger Weis Chief Executive Officer Acquired A 13,676 $0.00 $0 13,676 Direct
18 Aug, 2025 Ferdinand Groenewald Vice President Of Finance Acquired A 10,775 $0.00 $0 10,775 Direct
18 Aug, 2025 Ferdinand Groenewald Vice President Of Finance Acquired A 4,000 $0.00 $0 4,000 Direct
15 Jul, 2025 Michael Allen Jerman Director Acquired A 10,000 $0.00 $0 10,000 Direct
15 Jul, 2025 Michael Allen Jerman Director Acquired A 3,200 $0.00 $0 3,200 Direct
03 Jul, 2025 Jaime Vieser Director Acquired A 3,400 $0.00 $0 21,159 Direct
02 Jul, 2025 Holger Weis Chief Executive Officer Acquired A 130,000 $0.00 $0 130,000 Direct
03 Jul, 2025 Jaime Vieser Director Acquired A 6,400 $0.00 $0 6,400 Direct